德国生物新技术公司

欧盟国家于12月27日开始接种辉瑞和德国生物新技术公司联合研发的疫苗。

EU countries started vaccinations with the Pfizer-BioNTech shot on December 27 .

在世界上使用辉瑞和德国生物新技术公司联合研发的疫苗的国家中，以色列是接种率最高的。

Israel has one of the world 's highest vaccination rates using the Pfizer-BioNTech shots .

美国本周早些时候开始接种辉瑞和德国生物新技术公司联合开发的疫苗。

The U.S. started the rollout of vaccines developed by Pfizer and BioNTech earlier this week .

智利还批准了辉瑞和德国生物新技术公司联合研发的疫苗以及牛津—阿斯利康疫苗。

The country has also given the green light to the Pfizer-BioNTech vaccine and the Oxford-AstraZeneca vaccine .

第一批300万剂辉瑞与德国生物新技术公司联合研发的疫苗正在运往美国各地，每周都有更多疫苗到达。

The first batch of 3 million doses of the Pfizer-BioNTech vaccine is being shipped across the country with more to arrive each week .

继英国之后，加拿大和美国将成为首批开始接种由辉瑞和德国生物新技术公司联合研发的疫苗的西方国家。

Canada and the United States become the first Western nations after the UK to begin inoculations with the vaccine developed by Pfizer and Germany 's BioNTech .

欧洲药品管理局的一个专家小组将于周一召开会议，评估美国辉瑞公司和德国合作伙伴生物新技术公司联合开发的疫苗，预计该疫苗可在圣诞节前获得批准。

An expert panel of the European Medicines Agency will convene on Monday to evaluate the vaccine made by U.S. company Pfizer and German partner BioNTech , with an approval expected before Christmas .

这款疫苗由辉瑞及其德国合作伙伴德国生物新技术公司联合生产，是去年12月获得美国食品药品监督管理局紧急使用授权的首个疫苗。

The vaccine , made by Pfizer and its German partner BioNTech , was the first shot to be approved for emergency use by the FDA last December .